According to a recent LinkedIn post from Cooler Heads, the company is highlighting a patient experience using its Amma scalp cooling device during chemotherapy. The…
Patient Experience Underscores Market Potential for FDA-Cleared Scalp Cooling Device Read More »
Cooler Heads has made significant strides in cancer care by securing Medicaid coverage for scalp cooling therapies in New York, improving patient access.
New York Medicaid now funds a vital therapy to prevent chemo-induced hair loss, breaking down financial barriers for low-income cancer patients.
NY Medicaid Covers Scalp Cooling in Landmark Health Equity Move Read More »
The U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) to the LimiFlex Dynamic Sagittal Tether , a motion-preserving system for the treatment of lumbar spinal stenosis associated with Grade I degenerative spondylolisthesis following decompression.
FDA Grants PMA Approval to LimiFlex® Dynamic Sagittal Tether Read More »
CEO Andy Doraiswamy highlights the company’s growth and commercial momentum for its portfolio—including Dayspring®
NPCD endorsed by the American Venous Forum and the American Venous and Lymphatic Society as an effective option for lymphedema management.
First-in-Class Non-Invasive Ventilator Weaning Technology Fully Enrolled in Global Randomized Controlled Trial; Public Results Presentation Planned for late 2026 CRESTWOOD, KY, March 3, 2026 — Liberate Medical, a clinical-stage medical device company developing breakthrough neuromuscular electric
